1. Home
  2. NVCR vs RDW Comparison

NVCR vs RDW Comparison

Compare NVCR & RDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • RDW
  • Stock Information
  • Founded
  • NVCR 2000
  • RDW 2020
  • Country
  • NVCR Switzerland
  • RDW United States
  • Employees
  • NVCR N/A
  • RDW N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • RDW Military/Government/Technical
  • Sector
  • NVCR Health Care
  • RDW Industrials
  • Exchange
  • NVCR Nasdaq
  • RDW Nasdaq
  • Market Cap
  • NVCR 1.4B
  • RDW 1.2B
  • IPO Year
  • NVCR 2015
  • RDW N/A
  • Fundamental
  • Price
  • NVCR $13.77
  • RDW $8.05
  • Analyst Decision
  • NVCR Buy
  • RDW Buy
  • Analyst Count
  • NVCR 7
  • RDW 7
  • Target Price
  • NVCR $28.79
  • RDW $17.21
  • AVG Volume (30 Days)
  • NVCR 1.6M
  • RDW 9.0M
  • Earning Date
  • NVCR 10-30-2025
  • RDW 11-06-2025
  • Dividend Yield
  • NVCR N/A
  • RDW N/A
  • EPS Growth
  • NVCR N/A
  • RDW N/A
  • EPS
  • NVCR N/A
  • RDW N/A
  • Revenue
  • NVCR $630,160,000.00
  • RDW $261,353,000.00
  • Revenue This Year
  • NVCR $6.68
  • RDW $34.83
  • Revenue Next Year
  • NVCR $7.01
  • RDW $41.86
  • P/E Ratio
  • NVCR N/A
  • RDW N/A
  • Revenue Growth
  • NVCR 14.58
  • RDW N/A
  • 52 Week Low
  • NVCR $10.87
  • RDW $6.61
  • 52 Week High
  • NVCR $34.13
  • RDW $26.66
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 51.39
  • RDW 42.69
  • Support Level
  • NVCR $13.57
  • RDW $7.44
  • Resistance Level
  • NVCR $14.58
  • RDW $9.91
  • Average True Range (ATR)
  • NVCR 0.64
  • RDW 0.64
  • MACD
  • NVCR -0.05
  • RDW -0.16
  • Stochastic Oscillator
  • NVCR 49.59
  • RDW 16.96

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

Share on Social Networks: